BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1477 related articles for article (PubMed ID: 28971007)

  • 1. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
    Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
    Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
    Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
    J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI evaluation of asymmetry of nigrostriatal damage in the early stage of early-onset Parkinson's disease.
    Wang J; Yang QX; Sun X; Vesek J; Mosher Z; Vasavada M; Chu J; Kanekar S; Shivkumar V; Venkiteswaran K; Subramanian T
    Parkinsonism Relat Disord; 2015 Jun; 21(6):590-6. PubMed ID: 25825242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.
    Zhang Y; Wu IW; Tosun D; Foster E; Schuff N;
    PLoS One; 2016; 11(10):e0165540. PubMed ID: 27798653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's disease.
    Zhang Y; Wu IW; Buckley S; Coffey CS; Foster E; Mendick S; Seibyl J; Schuff N
    Mov Disord; 2015 Aug; 30(9):1229-36. PubMed ID: 25920732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrical diffusion tensor imaging indices of the rostral substantia nigra in Parkinson's disease.
    Prakash BD; Sitoh YY; Tan LC; Au WL
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1029-33. PubMed ID: 22705126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
    Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
    J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.
    Schwarz ST; Abaei M; Gontu V; Morgan PS; Bajaj N; Auer DP
    Neuroimage Clin; 2013; 3():481-8. PubMed ID: 24273730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra.
    Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP
    J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional anisotropy in the substantia nigra in Parkinson's disease: a complex picture.
    Lenfeldt N; Larsson A; Nyberg L; Birgander R; Forsgren L
    Eur J Neurol; 2015 Oct; 22(10):1408-14. PubMed ID: 26118635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI diffusion in Parkinson's disease: using the technique's inherent directional information to study the olfactory bulb and substantia nigra.
    Skorpil M; Söderlund V; Sundin A; Svenningsson P
    J Parkinsons Dis; 2012; 2(2):171-80. PubMed ID: 23939442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.